EP Patent

EP2948461A1 — Compounds and methods for treating bacterial infections

Assigned to Entasis Therapeutics Ltd · Expires 2015-12-02 · 10y expired

What this patent protects

Compounds of formula (I), pharmaceutically acceptable salts thereof, and uses of the compounds of formula (I) for treating bacterial infections are disclosed.

USPTO Abstract

Compounds of formula (I), pharmaceutically acceptable salts thereof, and uses of the compounds of formula (I) for treating bacterial infections are disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP2948461A1
Jurisdiction
EP
Classification
—
Expires
2015-12-02
Drug substance claim
No
Drug product claim
No
Assignee
Entasis Therapeutics Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.